The INSPIRE-Lung Study
- Conditions
- Lung Cancer
- Interventions
- Behavioral: LungTalkBehavioral: Non-tailored intervention - Standard of practice
- Registration Number
- NCT05824273
- Lead Sponsor
- Hackensack Meridian Health
- Brief Summary
LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- ≥20-pack-year smoking history;
- Individuals who currently smoke or quit smoking within the past 15 years
- Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed
- Has ever been diagnosed with lung cancer
- Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tailored health communication intervention (LungTalk) LungTalk Participants will receive the tailored health intervention "LungTalk". LungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool that is theoretically grounded in the Conceptual Model on Lung Cancer Screening Participation. Non-tailored Intervention Non-tailored intervention - Standard of practice Participants will receive non-tailored American Cancer Society (ACS) Lung Screening Informational Video as per standard of care. ACS Lung Screening Informational Video (ACS LSIV) is a non-tailored 5-minute video from the American Cancer Society about lung cancer screening designed for the lay individual.
- Primary Outcome Measures
Name Time Method Reaching screening eligible individuals via social media - Reach Within 4 years from the time the ad will appear on Facebook or until target enrollment is reached (whichever comes first) Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of people who saw the FBTA at least once.
Effectiveness of LungTalk - Knowledge Assessment At one week from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve total knowledge about lung screening. The total Knowledge of Lung Cancer Screening will be assessed with a 9-item multidimensional scale ranging from 0 to 9 with 0 being "No Knowledge" and 9 being "Complete knowledge".
Reaching screening eligible individuals via social media - Impressions Within 4 years from the time the ad will appear on Facebook or until target enrollment is reached (whichever comes first) Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of times the FBTA was on screen (may include multiple views of the ad by the same person/people).
Effectiveness of LungTalk - Perceived Benefits At one week from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Benefits. Perceived Benefits of Lung Cancer Screening is a 6-item scale with responses ranging from 1=strongly disagree to 4=strongly agree. The range of scores is 6 to 24 (higher perceived benefits).
Reaching screening eligible individuals via social media - Link Clicks Within 4 years from the time the ad will appear on Facebook or until target enrollment is reached (whichever comes first) Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of clicks on the link within the FBTA that led to the REDCap survey platform of the study.
Effectiveness of LungTalk - Perceived Barriers At one week from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Barriers. Perceived Barriers to Lung Cancer Screening. This scale has 17 items with four-point Likert responses where 1=strongly disagree and 4=strongly agree. The range of scores is 17 to 68 (higher perceived barriers).
Effectiveness of LungTalk - Screening Uptake At 6 months from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Screening Uptake, Lung Cancer Screening Uptake will be assessed via self-report via the stages of adoption algorithm for lung screening. There are seven stages (unaware, aware but unengaged, undecided, decided not to act, decided to act, action, and maintenance).
Effectiveness of LungTalk - Perceived Risk At one week from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Risk. Perceived Risk of Lung Cancer is a 3-item scale with Likert-type responses. The range of scores is 3 to 12 (higher perceived risk of lung cancer).
Effectiveness of LungTalk - Self-Efficacy At one week from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Self-Efficacy. Self-Efficacy for Lung Cancer Screening will be assessed using a scale with nine items with a four-point Likert response option to assess individual beliefs about ability to arrange and complete a low-dose computed tomography (LDCT) to screen for lung cancer. The range of scores is 9 to 36 (higher levels of self-efficacy).
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion At 6 months from baseline survey completion The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Occurrence of a Patient-Clinician Discussion. Occurrence of a Patient-Clinician Discussion about Lung Cancer Screening will be assessed with a single item requiring dichotomous (Y/N) response regarding a discussion with their healthcare provider.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hackensack Meridian Health - Center for Discovery and Innovation
🇺🇸Nutley, New Jersey, United States